$10.49 +0.01 (0.05%)

Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share (OACC)

Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share (OACC) is a special purpose acquisition company (SPAC) focused on identifying and acquiring innovative companies within the life sciences sector. Backed by Oaktree Capital Management, it aims to facilitate mergers or acquisitions that enhance value in the healthcare and life sciences industries. The company provides a platform for private companies to access public markets and accelerate growth through strategic partnerships.

🚫 Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share does not pay dividends

Company News

Verona Pharma to Report First Quarter 2025 Financial Results and Provide Corporate Update
GlobeNewswire Inc. • N/A • April 15, 2025

Verona Pharma reported strong financial results for Q4 and 2024, with its product Ohtuvayre (ensifentrine) recording net sales of $36.6 million in Q4 and $42.3 million in 2024. The company also announced an amended strategic financing with Oaktree and OMERS, including a term loan facility increase and access to additional funding.